Navigation Links
Verenium Reports Financial Results For The Second Quarter And Six Months Ended June 30, 2012
Date:8/6/2012

SAN DIEGO, Aug. 6, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported operating highlights and financial results for the second quarter and six months ended June 30, 2012.

"The first half of the year proved to be an important turning point for Verenium," said James Levine, President & Chief Executive Officer at Verenium.  "With the recent move into our new facility completed and our debt repaid, we are focused on growing our business through the sales of our current marketed products, developing our product pipeline, and establishing future collaborations and partnerships."

Company HighlightsSince the beginning of 2012, the Company has made progress on both operational and financial fronts.  Recent accomplishments include:

  • Completed a strategic transaction with DSM Food Specialties, B.V. ("DSM"), including the sale of the Company's oilseed processing business, for total consideration of $37 million;
  • Repurchased $34.9 million in convertible notes outstanding, retiring all of the Company's remaining debt;
  • Announced that the Company's next-generation enzyme breaker was authorized for use in hydraulic fracturing by the Environmental Protection Agency (EPA);
  • Completed moving into the Company's new office and state-of-the-art laboratory and pilot plant facility in San Diego, California; and
  • Ended the second quarter with unrestricted cash of $14.4 million and $5.7 million in restricted cash.
  • Financial ResultsIn the commentary below, the operating results of the Company's oilseed processing business, sold to DSM in March 2012, for prior periods are included in continuing operations.

    Revenues

    Revenues for the periods ended June 30, 2012 and 2
    '/>"/>

    SOURCE Verenium Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. Verenium Corporation To Announce Second Quarter 2012 Financial Results
    2. Verenium Announces EPA Authorization To Market Its Next-Generation Enzyme Breaker For Hydraulic Fracturing
    3. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
    4. Verenium Corporation Named One Of The 2012 Best Places to Work in San Diego
    5. Verenium Corporation To Announce First Quarter 2012 Financial Results
    6. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
    7. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
    8. Verenium to Present at Baird Clean Technology Conference
    9. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    10. Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
    11. Discovery Labs Reports Second Quarter 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/20/2014)... PLAINSBORO, N.J. (PRWEB) October 20, 2014 ... that the Sidney Kimmel Cancer Center at Thomas ... program. , Through the Strategic Alliance Partnership ... and OncLive will collaborate to raise awareness of ... cancer treatment, and other projects. Clinicians and other ...
    (Date:10/19/2014)... , Oct. 19, 2014 NextCODE Health, which enables ... genome in real time, today announced the launch of its ... Exchange , at the American Society of Human Genetics (ASHG) ... learn more, sign up and apply for free beta access, ... features and benefits can be viewed here . ...
    (Date:10/19/2014)... (PRWEB) October 19, 2014 The Asian Orthopedic ... market in Asia with analysis and forecast of revenue. The ... to grow to around $416.5 million by 2018, at a ... through the TOC of the Asian Orthopedic braces and support ... provided. This also provides a glimpse of the segmentation of ...
    (Date:10/18/2014)... October 18, 2014 The report ... Trends and Forecasts to 2019", analyzes the global ... order to understand the industry details such as ... across various geographic regions. , Browse 81 Market ... Slides and in-depth TOC on “1,6-Hexanediol Market by ...
    Breaking Biology Technology:Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 2The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 41,6-Hexanediol Market Projected to Reach $916.1 Million at a CAGR of 8.3% by 2019 – Report by MarketsandMarkets 21,6-Hexanediol Market Projected to Reach $916.1 Million at a CAGR of 8.3% by 2019 – Report by MarketsandMarkets 31,6-Hexanediol Market Projected to Reach $916.1 Million at a CAGR of 8.3% by 2019 – Report by MarketsandMarkets 41,6-Hexanediol Market Projected to Reach $916.1 Million at a CAGR of 8.3% by 2019 – Report by MarketsandMarkets 5
    ... BEDFORD, Mass. and MADISON, Wis., July 17 ,Hologic, Inc. ... (Nasdaq:,TWTI) ("Third Wave"), today jointly announced the expiration of ... wholly-owned subsidiary Thunder,Tech Corp. (the "Purchaser") for all outstanding ... period expired, as scheduled, at 12:00,midnight, New York City ...
    ... Will Focus on Strategies to Promote Legislative Pathway for ... ... (Nasdaq:,INSM), a developer of follow-on biologics and biopharmaceuticals for unmet,medical needs, ... Ways and Means Committee from 2001 to 2007, has been,retained by ...
    ... Ablative Solution to Treat Deep Wrinkles and Significant Photo Damage,- ... Newest Addition Broadens Affirm(TM) Family to Provide Industry,s Most ... Comprehensive Anti-Aging Solution, ... ), a leading developer and manufacturer of a broad array ...
    Cached Biology Technology:Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period 2Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period 3Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period 4Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period 5Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor 2Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor 3Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor 4Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy 2Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy 3Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy 4
    (Date:10/16/2014)... and Washington land managers have a new synthesis of ... moist mixed-conifer (MMC) forests in the two states. ... in Eastern Oregon and Washington: A Synthesis of the ... a general technical report published by the U.S. Forest ... to a request from managers for a synthesis of ...
    (Date:10/16/2014)... efficiently, they are anything but sustainable: environmental damage ... is becoming increasingly evident. Despite their disadvantages, however, ... regarded as the sole possibility of achieving higher ... Bernhard Schmid, an ecology professor at the University ... agriculture and forestry. After all, a new study ...
    (Date:10/16/2014)... Calif. (October 16, 2014) – Post-menopausal women experienced ... on hormone levels or genital bleeding, after 12 ... an investigational fermented soy germ-based nutritional supplement previously ... to a new peer-reviewed pilot study reported in ... (NAMS) annual scientific meeting. , "These data ...
    Breaking Biology News(10 mins):New report synthesizes best available science on management of moist mixed-conifer forests 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2
    ... In new research from Saint Louis University, investigators have ... responsible for the series of cellular events that lead to ... found that the brain toxin DOPAL plays a key role ... In earlier research, Saint Louis University investigators found ...
    ... about how the flea jumps, think again. In 1967, ... to catapult themselves into the air in an elastic ... debate raged about exactly how fleas harness this explosive ... hypotheses, but neither had access to the high speed ...
    ... 9, 2011 Qqest and M2SYS Technology, a global ... that allows Qqest to offer TimeForce time and attendance ... identification technology at their PC. M2SYS, RightPunch(TM) ... to seamlessly interface with Qqest,s TimeForce time and ...
    Cached Biology News:SLU research implicates natural toxin as triggering Parkinson's disease 244-year-old mystery of how fleas jump resolved 244-year-old mystery of how fleas jump resolved 3Qqest Teams Up With M2SYS to Add Biometric Technology at the Desktop to TimeForce Time and Attendance System 2Qqest Teams Up With M2SYS to Add Biometric Technology at the Desktop to TimeForce Time and Attendance System 3
    ... 140kDa GenBank Accession ... amino acids 926-941 (DKKVKPPFIPTIRGRE) of human PRK2. ... Quality Assurance Routinely evaluated by ... Stability 1 year at ...
    Replacement Parts for Electrophoresis Apparatus...
    Rabbit anti-phospho-EGFr (Tyr992) - Concentrate...
    EMBP (FL-222)...
    Biology Products: